The Trump administration has awarded Kodak a $765 million government loan under the Defense Production Act to help speed the domestic manufacturing of certain medical drugs.

A new division, Kodak Pharmaceuticals, is expected to create 350 jobs, senior administration officials said during a call with reporters Tuesday. The move is billed as part of a larger effort to secure a United States supply of critical pharmaceutical ingredients and modernize the Strategic National Stockpile.

The U.S. International Development Finance Corporation, the agency that engineered the deal, has been working with the Department of Defense to relocate important supply chains out of China for months at the president’s direction.

Continue reading…

https://www.washingtonexaminer.com/news/trump-reroutes-pharmaceutical-manufacturing-from-china-to-new-york-kodak-plant